* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Thursday, October 9, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    Israel’s Entertainment Industry Is Being Targeted by the Left in Hollywood and the Right at Home – The Wall Street Journal

    Inside the Fierce Clash Shaping Israel’s Entertainment Industry: Hollywood vs. Local Voices

    Offset Is Ready To Finalize Divorce With Cardi B for a Major Reason – Yahoo

    Offset Poised to Finalize Divorce from Cardi B for a Major Reason

    Beyond the Stage: 8 Performing Arts Centers Driving Entertainment and Education – Livability.com

    Beyond the Stage: 8 Performing Arts Centers Transforming Entertainment and Education

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    ENERCON and Biome collaborate for wind turbine noise reduction technology – Yahoo Finance

    ENERCON and Biome Join Forces to Revolutionize Wind Turbine Noise Reduction

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    Is Light-Speed Analog Computing the Future of Technology? – BIOENGINEER.ORG

    Could Light-Speed Analog Computing Transform the Future of Technology?

    ARM Institute opens technology project call to speed submarine manufacturing – The Robot Report

    ARM Institute Unveils Cutting-Edge Technology Project to Revolutionize Submarine Manufacturing

    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    What the Recent Price Surge Means for Figure Technology Solutions After SEC Settlement – Yahoo Finance

    What the Recent Price Surge Reveals About Figure Technology Solutions Following SEC Settlement

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    Israel’s Entertainment Industry Is Being Targeted by the Left in Hollywood and the Right at Home – The Wall Street Journal

    Inside the Fierce Clash Shaping Israel’s Entertainment Industry: Hollywood vs. Local Voices

    Offset Is Ready To Finalize Divorce With Cardi B for a Major Reason – Yahoo

    Offset Poised to Finalize Divorce from Cardi B for a Major Reason

    Beyond the Stage: 8 Performing Arts Centers Driving Entertainment and Education – Livability.com

    Beyond the Stage: 8 Performing Arts Centers Transforming Entertainment and Education

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Row K Entertainment Emerges as Major New Hollywood Buyer With Splashy TIFF Shopping Spree – TheWrap

    Charlie Hunnam Reflects on Playing a Serial Killer in Monster: The Ed Gein Story – Yahoo

    Charlie Hunnam Reveals the Dark Challenges of Playing a Serial Killer in Monster: The Ed Gein Story

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

    “Reba” cast, then and now: See the stars 24 years later (and who’s reunited for another show) – Yahoo

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology
    ENERCON and Biome collaborate for wind turbine noise reduction technology – Yahoo Finance

    ENERCON and Biome Join Forces to Revolutionize Wind Turbine Noise Reduction

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    US and investors gambling on unproven nuclear technology, warn experts – Financial Times

    Is Light-Speed Analog Computing the Future of Technology? – BIOENGINEER.ORG

    Could Light-Speed Analog Computing Transform the Future of Technology?

    ARM Institute opens technology project call to speed submarine manufacturing – The Robot Report

    ARM Institute Unveils Cutting-Edge Technology Project to Revolutionize Submarine Manufacturing

    Forget Cowbells. Cows Wear High-Tech Collars Now. – The New York Times

    Ditch the Cowbells: Discover the High-Tech Collars Transforming Cattle Care

    What the Recent Price Surge Means for Figure Technology Solutions After SEC Settlement – Yahoo Finance

    What the Recent Price Surge Reveals About Figure Technology Solutions Following SEC Settlement

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients

July 11, 2023
in Health
Aflibercept 8 mg first to achieve extended injection intervals of 16 weeks in up to 89% of patients
Share on FacebookShare on Twitter

Not intended for U.S. and UK Media

Berlin, September 8, 2022 – Bayer AG today announced the primary endpoint was met in two pivotal trials investigating aflibercept 8 mg with 12- and 16-week dosing regimens in patients with neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME) at week 48. The Phase III PULSAR trial in nAMD and Phase II/III PHOTON trial in DME evaluated the non-inferiority of the two aflibercept 8 mg extended-dosing regimens in terms of best corrected visual acuity (BCVA), compared to Eylea® (aflibercept 2 mg) dosed every 8-week following initial monthly doses. In these trials, the safety of aflibercept 8 mg was consistent with the well-established safety profile of Eylea. Bayer will submit these data to regulatory authorities outside of the U.S..

“These groundbreaking results are excellent news for patients. These outcomes have shown that aflibercept 8 mg not only improved vision with less frequent injections, but also demonstrated a similar safety profile to Eylea,” said Jean-François Korobelnik, Professor of Ophthalmology and Head of the Department of Ophthalmology at University Hospital of Bordeaux in France and a trial investigator.

“These pivotal aflibercept 8 mg trials demonstrated that nearly 90% of patients with diabetic macular edema and almost 80% of patients with wet age-related macular degeneration were able to maintain a 16-week dosing regimen,” said David Brown, M.D., FACS, Director of Research at Retina Consultants of Texas in the U.S. and a trial investigator. “These unprecedented durability data coupled with a safety profile consistent with that of Eylea support aflibercept 8 mg as a potential new standard-of-care in these diseases.”

Aflibercept 8 mg was investigated in two double-masked, active-controlled pivotal trials – PULSAR (n=1009) in nAMD and PHOTON (n=658) in DME – to evaluate efficacy and safety compared to Eylea. Both trials were conducted in multiple centers globally with similar designs and endpoints. At 48-weeks, both trials met their primary endpoints of non-inferiority of aflibercept 8 mg to Eylea. Additional results were as follows:

In the aflibercept 8 mg 16-week dosing groups, 77% of nAMD patients in PULSAR (n=312) and 89% of DME patients in PHOTON (n=156) were able to maintain 16-week injection intervals with an average of 5 injections in the first year.

In the aflibercept 8 mg 12-week dosing groups, 79% of nAMD patients in PULSAR (n=316) and 91% of DME patients in PHOTON (n=300) were able to maintain 12-week injection intervals with an average of 6 injections in the first year.

In a pooled analysis of aflibercept 8 mg dosing groups, 83% of nAMD patients in PULSAR and 93% of DME patients in PHOTON maintained 12-week dosing or longer.

The safety of aflibercept 8 mg in both trials was similar to the well-established safety profile of Eylea and consistent with the safety of Eylea observed in previous clinical trials. Comparing aflibercept 8 mg to Eylea, the rates of serious ocular adverse events were 1.6% versus 0.6% in PULSAR and 0.6% versus 0.6% in PHOTON. The rates of intraocular inflammation for aflibercept 8 mg compared to Eylea were 0.7% versus 0.6% in PULSAR and 0.8% versus 0.6% in PHOTON. There were no clinically relevant differences in intraocular pressure between the treatment groups. In both trials, there were no cases of retinal vasculitis and no new safety signals.

“These data mark a new era, as the extended dosing intervals of aflibercept 8 mg significantly reduced the treatment burden for a large majority of patients compared to the more intensive injection frequency currently required,” said Dr. Christian Rommel, Member of the Executive Committee of Bayer`s Pharmaceutical Division and Head of Research and Development. “All of this was accomplished while improving and maintaining vision with comparable safety to Eylea.”

Detailed efficacy and safety data from PHOTON and PULSAR are planned for presentation at an upcoming medical meeting.

Aflibercept 8 mg is being jointly developed by Bayer and Regeneron. Regeneron maintains exclusive rights to Eylea and aflibercept 8 mg in the United States. Bayer has licensed the exclusive marketing rights outside the United States, where the companies share equally the profits from sales of Eylea.

Aflibercept 8 mg is investigational, and its safety and efficacy have not yet been evaluated by any regulatory authority.

About nAMD and DME

Neovascular (wet) age-related macular degeneration (nAMD) is an eye disease that progresses rapidly and if left untreated can lead to vision loss in as little as three months. nAMD is one of the leading causes of irreversible blindness and vision impairment around the world. nAMD may affect people as they age. It occurs when abnormal blood vessels grow and leak fluid under the macula, the part of the eye responsible for sharp central vision and seeing fine detail. This fluid can damage and scar the macula, which can cause vision loss. 196 million people worldwide are living with AMD – it is anticipated that this figure will increase to 288 million by 2040.

Diabetic macular edema (DME) is a common complication in eyes of people living with diabetes. DME occurs when high levels of blood sugar lead to damaged blood vessels in the eye that leak fluid into the macula. This can lead to vision loss and, in some cases, blindness. Globally, 146 million people are currently living with diabetic retinopathy (DR), which can develop into a more serious condition which is diabetic macular edema (DME).

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.

Find more information at https://pharma.bayer.com/

Follow us on Facebook: http://www.facebook.com/bayer

Follow us on Twitter: @BayerPharma

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Bayer.com – https://www.bayer.com/media/en-us/aflibercept-8-mg-first-to-achieve-extended-injection-intervals-of-16-weeks-in-up-to-89-of-patients/

Tags: AfliberceptFirsthealth
Previous Post

Kimberly Mathisen appointed to the Supervisory Board of Bayer AG

Next Post

Bayer completes sale of its Environmental Science Professional business to Cinven

IRONMAN World Championship Kona 2025: Date, start time and how to watch live – TRI247

IRONMAN World Championship Kona 2025: Date, start time and how to watch live – TRI247

October 9, 2025
Canada’s economy is in serious trouble. Now Mark Carney is coming to Washington to talk tariffs – CNN

Canada’s economy is in serious trouble. Now Mark Carney is coming to Washington to talk tariffs – CNN

October 9, 2025
Israel’s Entertainment Industry Is Being Targeted by the Left in Hollywood and the Right at Home – The Wall Street Journal

Inside the Fierce Clash Shaping Israel’s Entertainment Industry: Hollywood vs. Local Voices

October 9, 2025
Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition – The American Journal of Managed Care® (AJMC®)

Better Food, Better Health: Redefining Chronic Disease Care Through Nutrition – The American Journal of Managed Care® (AJMC®)

October 9, 2025
WATCH: ‘Come and get me,’ Pritzker responds to Trump’s call to put Illinois governor in jail – PBS

WATCH: ‘Come and get me,’ Pritzker responds to Trump’s call to put Illinois governor in jail – PBS

October 9, 2025
New Method to Monitor Wild Reindeer Populations Could Boost Conservation Efforts – Bioengineer.org

New Method to Monitor Wild Reindeer Populations Could Boost Conservation Efforts – Bioengineer.org

October 8, 2025
Scientists just proved the moai could walk, solving a 500-year mystery – ScienceDaily

Scientists Finally Reveal How the Moai Statues Could “Walk,” Solving a 500-Year Mystery

October 8, 2025
GenoPalate Advances Its Science Again With Diet Snapshot – Yahoo Finance

GenoPalate Advances Its Science Again With Diet Snapshot – Yahoo Finance

October 8, 2025
Horses making the rounds at Florida hospitals – The Union Democrat

Horses Bringing Joy and Healing to Florida Hospitals

October 8, 2025
ENERCON and Biome collaborate for wind turbine noise reduction technology – Yahoo Finance

ENERCON and Biome Join Forces to Revolutionize Wind Turbine Noise Reduction

October 8, 2025

Categories

Archives

October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (858)
  • Economy (879)
  • Entertainment (21,752)
  • General (17,490)
  • Health (9,921)
  • Lifestyle (891)
  • News (22,149)
  • People (880)
  • Politics (890)
  • Science (16,089)
  • Sports (21,379)
  • Technology (15,859)
  • World (862)

Recent News

IRONMAN World Championship Kona 2025: Date, start time and how to watch live – TRI247

IRONMAN World Championship Kona 2025: Date, start time and how to watch live – TRI247

October 9, 2025
Canada’s economy is in serious trouble. Now Mark Carney is coming to Washington to talk tariffs – CNN

Canada’s economy is in serious trouble. Now Mark Carney is coming to Washington to talk tariffs – CNN

October 9, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version